Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Surgery. 2015 Jun 9;158(3):819–826. doi: 10.1016/j.surg.2015.04.017

Figure 1. JQ1 decreased neuroblastoma cell viability.

Figure 1

(A) JQ1 treatment (1 μM) decreased cell viability of all human neuroblastoma cell lines examined, BE(2)-C, IMR-32, JF, BE(2)-M17, SK-N-SH, and SK-N-DZ (mean ± SEM; *=p < 0.05 vs. CON). Cell viability was measured over a four-day period using CCK-8 assay. (B) JQ1 treatment (1 μM) decreased N-myc protein levels in all neuroblastoma cell lines examined except in MYCN-non-amplified SK-N-SH cells. β-actin was probed for protein loading control.